3 drug(s) with this reaction
209 total reports
Application Site Burn has been reported as an adverse reaction across 3 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 209 adverse event reports mention application site burn in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with application site burn, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have application site burn listed in their FDA adverse event reports, sorted by report count:
In addition to application site burn, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
3 drug(s) manufactured by Chattem Inc have application site burn listed in their FDA adverse event reports: MENTHOL, CAMPHOR, MENTHOL, TROLAMINE SALICYLATE.
There are a combined 209 reports of application site burn across 3 Chattem Inc drug(s) in the FDA adverse event database.